ONC — Oncimmune Holdings Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- £1.27m
- £5.55m
- £2.74m
Annual balance sheet for Oncimmune Holdings, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.24 | 8.63 | 1.43 | 3.21 | 0.846 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.79 | 6.85 | 1.67 | 1.92 | 0.645 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 6.23 | 16.1 | 3.61 | 5.57 | 1.85 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.37 | 1.59 | 1.34 | 0.591 | 0.424 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 10.3 | 24.3 | 10.2 | 8.44 | 4.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.47 | 9.77 | 7.82 | 1.42 | 2.67 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.5 | 19.1 | 14.3 | 7.78 | 7.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -0.194 | 5.23 | -4.18 | 0.657 | -2.4 |
| Total Liabilities & Shareholders' Equity | 10.3 | 24.3 | 10.2 | 8.44 | 4.9 |
| Total Common Shares Outstanding |